Real-time enrollment status for this primary immune deficiency clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 8:16 AM UTC
| NCT Number | NCT05787574 |
| Recruiting Status | Recruiting |
| Condition | Primary Immune Deficiency |
| Phase | PHASE2 |
| Target Enrollment | 39 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | June 2, 2026 (Jun 2, 2026) |
As of July 19, 2026: Clinical trial NCT05787574 is currently recruiting participants. This phase2 study for primary immune deficiency is actively seeking new participants at 13 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05787574 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05787574 was last updated Jun 2, 2026 (June 2, 2026). HelloStudys verifies this status automatically.